Gestational Diabetes Mellitus Risk Factors in Pregnant Women Attending Public Health Institutions in Ethiopia's Sidama Region: An Unmatched Case-Control Study
DOI: https://doi.org/10.2147/dmso.s457739
2024-06-08
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Girma Tenkolu Bune 1, 2 1 School of Public Health, College of Medicine and Health Science, Dilla University, Dilla Town, SNNPR, Ethiopia; 2 Departiment of Public Health, Rift Valley University, Hawassa Town, Sidama Regional State, Ethiopia Correspondence: Girma Tenkolu Bune, Email ; Background: Gestational diabetes mellitus (GDM), a chronic condition leading to glucose intolerance during pregnancy, is common in low- and middle-income countries, posing health risks to both the mother and fetus. Limited studies have been done in Ethiopia, especially using WHO's 2013 universal screening criteria. Therefore, this study aimed to evaluate the risk factors linked to GDM in women attending antenatal (ANC) clinics in Hawassa town public health institutions, located in the Sidama regional state of Ethiopia. Methods: An Unmatched case-control study was carried out in Ethiopia's Sidama Region from April 1st to June 10th, 2023, involving 510 pregnant women. The Oral Glucose Tolerance Test (OGTT) was utilized for universal screening and diagnosing GDM based on the updated 2013 WHO diagnostic criteria. Data analysis included descriptive and analytical statistics, with variables having p-values below 0.1 deemed suitable for bivariate analysis. Statistical significance was assessed using the adjusted odds ratio (AOR) with a 95% confidence interval and a p-value < 0.05. Results: The study involved 633 participants (255 cases and 378 controls), resulting in a 100% response rate, with women having an average age of 29.03 years.Variables such as: age at first conception (AOR=0.97, P=0.01, 95% CI (0.95,0.99)), urban residency (AOR=1.66, P< 0.01, 95% CI(01.14,2.40)), widowed marital status (AOR=0.30, P=0.02, 95% CI (0.30,0.90)), parity (AOR=1.10, P< 0.01, 95% CI (1.03,1.17)), history of stillbirth (AOR=1.15, P=0.03, 95% CI(1.04,2.30)), and previous cesarean section (AOR=1.86, P=0.01, 95% CI (1.13,2.66)) were identified as independent factors associated with GDM. Conclusion: The study concluded that factors like age at first conception, place of residence, marital status, parity, history of Caesarian section, and stillbirth were independently associated with GDM. Surprisingly, upper arm circumference (MUAC), a proxy for pre-gestational BMI, was not identified as a risk factor for GDM. It is recommended that healthcare providers conduct comprehensive GDM risk assessments in pregnant women to identify and address risk factors, and propose specific screening and intervention strategies. Keywords: women, WHO, pregnancy, diabetes, DM, factors, screening, OGTT, glucose, SSA, Sub-Saharan Africa, SSA, Ethiopia, Sidama, Hawassa Insufficient synthesis of pancreatic insulin or inappropriate usage of it results in diabetes mellitus (DM). 1,2 DM encompasses Type I and Type II pre-gestational diabetes as well as gestational diabetes (GDM). 1,3 GDM is a prevalent chronic condition that develops during pregnancy, characterized by any level of glucose intolerance typically first identified during pregnancy due to physiological changes in glucose metabolism, placental output, and maternal insulin resistance. 1–5 GDM is diagnosed through specific criteria that cover over 90% of diabetes cases during pregnancy. 1,6 The diagnostic criteria typically involve screening pregnant women for glucose intolerance using tests such as the Oral Glucose Tolerance Test (OGTT) or the Glucose Challenge Test (GCT). These tests assess blood glucose levels at different intervals after an overnight fast of 8 to 14 hours, administering 75 gm anhydrous glucose in 250–300 mL water. The WHO 2013 guidelines set diagnostic thresholds for GDM. 7,8 GDM is a significant global public health issue with both short- and long-term health risks for mothers and fetuses, 3,9–11 including complications like abortion, preterm birth, malformations, cognitive delays, and maternal health issues. 1–5,12–14 This condition also increases the risk of developing diabetes and cardiovascular diseases and results in high healthcare costs and elevated maternal and infant mortality rates. 15 Women with GDM have a higher likelihood of developing type 2 diabetes, 16 with implications for future generations as well. 17 The prevalence of GDM varies globally depending on demographics, racial/ethnic backgrounds, population characteristics, testing methods, and diagnostic criteria. 1 Notably, GDM is prevalent in low- and middle-income countries, including varying rates across Africa. 12 In Ethiopia, studies show a prevalence ranging from 12.04% to 16.9% among pregnant women, 1,3 with factors such as inadequate dietary variety, high BMI, and fami -Abstract Truncated-
endocrinology & metabolism